Within-Trial Evaluation of Medical Resources, Costs, and Quality of Life Among Patients With Type 2 Diabetes Participating in the Exenatide Study of Cardiovascular Event Lowering (EXSCEL).

MLA

Reed, Shelby D., et al. “Within-Trial Evaluation of Medical Resources, Costs, and Quality of Life Among Patients With Type 2 Diabetes Participating in the Exenatide Study of Cardiovascular Event Lowering (EXSCEL).” Diabetes Care, vol. 43, no. 2, Feb. 2020, pp. 374–81. EBSCOhost, https://doi.org/10.2337/dc19-0950.

APA

Reed, S. D., Li, Y., Dakin, H. A., Becker, F., Leal, J., Gustavson, S. M., Kartman, B., Wittbrodt, E., Mentz, R. J., Pagidipati, N. J., Bethel, M. A., Gray, A. M., Holman, R. R., & Hernandez, A. F. (2020). Within-Trial Evaluation of Medical Resources, Costs, and Quality of Life Among Patients With Type 2 Diabetes Participating in the Exenatide Study of Cardiovascular Event Lowering (EXSCEL). Diabetes Care, 43(2), 374–381. https://doi.org/10.2337/dc19-0950

Chicago

Reed, Shelby D, Yanhong Li, Helen A Dakin, Frauke Becker, Jose Leal, Stephanie M Gustavson, Bernt Kartman, et al. 2020. “Within-Trial Evaluation of Medical Resources, Costs, and Quality of Life Among Patients With Type 2 Diabetes Participating in the Exenatide Study of Cardiovascular Event Lowering (EXSCEL).” Diabetes Care 43 (2): 374–81. doi:10.2337/dc19-0950.